Similarly, 83% of SMCs in patients with no/mild CAD demonstrated expression of p‐Smad3 in the media of their coronary arteries; this was reduced to 41% in patients with moderate CAD and 16% in patients with severe CAD (Fig 5F). This evidence concerns the gene SMAD3 and coronary artery disorder.